OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 72 filers reported holding OCULAR THERAPEUTIX INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $1,000 | 0.0% | 125 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $1,000 | 0.0% | 125 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $1,000 | 0.0% | 125 | 0.0% | 0.00% | +100.0% |
Q1 2016 | $1,000 | 0.0% | 125 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $1,000 | -50.0% | 125 | 0.0% | 0.00% | -66.7% |
Q3 2015 | $2,000 | -33.3% | 125 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $3,000 | -40.0% | 125 | 0.0% | 0.00% | -50.0% |
Q1 2015 | $5,000 | -44.4% | 125 | -66.7% | 0.01% | -40.0% |
Q4 2014 | $9,000 | +125.0% | 375 | +50.0% | 0.01% | +100.0% |
Q3 2014 | $4,000 | – | 250 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 6,122,089 | $31,590 | 100.00% |
Opaleye Management Inc. | 5,780,000 | $29,824,800 | 7.13% |
DELTEC ASSET MANAGEMENT LLC | 1,974,797 | $10,189,953 | 2.23% |
Lynwood Capital Management Inc. | 262,500 | $1,354,500 | 1.72% |
Endurant Capital Management LP | 368,438 | $1,901,140 | 1.66% |
Knoll Capital Management, LLC | 200,000 | $1,032,000 | 1.25% |
Knoll Capital Management, LLC | 95,800 | $814,300 | 0.99% |
SECTORAL ASSET MANAGEMENT INC | 802,680 | $4,141,829 | 0.69% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 300,977 | $1,553,041 | 0.22% |
Cormorant Asset Management, LP | 645,000 | $3,328,200 | 0.19% |